drugset / Trial / NCT01694355

The Impact of Severe Vitamin D Deficiency and Its Correction on Bone Mineral Density (BMD) in Postmenopausal Women

NCT01694355

Completed 32 enrolled Soroka University Medical Center
NaSingle-groupOpen-labelTreatment

Summary

It is well known that postmenopausal women are at risk for osteoporosis. The study hypothesis is that vitamin D deficiency (≤17.5nmol/L) is frequently associated with osteomalacia and will cause low BMD estimation in DXA scan due to insufficient bone mineralization. We assume that among these postmenopausal women, Vitamin D treatment will improve bone mineralization and will cause a rapid increase in BMD. According to the results, bisphosphonates therapy may be an unnecessary treatment. The objective of this study is to evaluate the impact of severe vitamin D deficiency and its correction on Bone Mineral Density (BMD) in postmenopausal women.

Timeline

Start
2012-10
Primary completion
2018-10
Completion
2018-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Vitamin D Other / unclassified

Indications